Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.
Identifieur interne : 000057 ( Main/Exploration ); précédent : 000056; suivant : 000058Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.
Auteurs : Michelle Murti [Canada] ; Christina K. Fung [Canada] ; Kathy Chan [Canada] ; Mark Bigham [Canada]Source :
- American journal of infection control [ 1527-3296 ] ; 2018.
Descripteurs français
- KwdFr :
- Antiviraux (administration et posologie), Chimioprévention (), Colombie-Britannique (épidémiologie), Flambées de maladies, Grippe humaine (), Grippe humaine (anatomopathologie), Grippe humaine (épidémiologie), Humains, Infection croisée (), Infection croisée (anatomopathologie), Infection croisée (épidémiologie), Soins de longue durée, Temps, Établissements de santé, Études rétrospectives.
- MESH :
- administration et posologie : Antiviraux.
- anatomopathologie : Grippe humaine, Infection croisée.
- épidémiologie : Colombie-Britannique, Grippe humaine, Infection croisée.
- Chimioprévention, Flambées de maladies, Grippe humaine, Humains, Infection croisée, Soins de longue durée, Temps, Établissements de santé, Études rétrospectives.
English descriptors
- KwdEn :
- Antiviral Agents (administration & dosage), British Columbia (epidemiology), Chemoprevention (methods), Cross Infection (epidemiology), Cross Infection (pathology), Cross Infection (prevention & control), Disease Outbreaks, Health Facilities, Humans, Influenza, Human (epidemiology), Influenza, Human (pathology), Influenza, Human (prevention & control), Long-Term Care, Retrospective Studies, Time.
- MESH :
- chemical , administration & dosage : Antiviral Agents.
- geographic , epidemiology : British Columbia.
- epidemiology : Cross Infection, Influenza, Human.
- methods : Chemoprevention.
- pathology : Cross Infection, Influenza, Human.
- prevention & control : Cross Infection, Influenza, Human.
- Disease Outbreaks, Health Facilities, Humans, Long-Term Care, Retrospective Studies, Time.
Abstract
To assess the duration of antiviral prophylaxis (AP), we conducted a retrospective outbreak review over 3 seasons, looking for acute respiratory illness (ARI) onset after 5 days of AP. Of 114 facility-level outbreaks with 352 unit-level outbreaks, we found only 1 case of laboratory-confirmed influenza after 5 days of AP. New cases of ARI after 5 days of AP should be investigated, and recommendations for AP duration could be shortened to 7-8 days or less.
DOI: 10.1016/j.ajic.2018.01.004
PubMed: 29502884
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.</title>
<author><name sortKey="Murti, Michelle" sort="Murti, Michelle" uniqKey="Murti M" first="Michelle" last="Murti">Michelle Murti</name>
<affiliation wicri:level="1"><nlm:affiliation>Fraser Health Authority, Surrey, Canada. Electronic address: Michelle.murti@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fung, Christina K" sort="Fung, Christina K" uniqKey="Fung C" first="Christina K" last="Fung">Christina K. Fung</name>
<affiliation wicri:level="1"><nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chan, Kathy" sort="Chan, Kathy" uniqKey="Chan K" first="Kathy" last="Chan">Kathy Chan</name>
<affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bigham, Mark" sort="Bigham, Mark" uniqKey="Bigham M" first="Mark" last="Bigham">Mark Bigham</name>
<affiliation wicri:level="1"><nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29502884</idno>
<idno type="pmid">29502884</idno>
<idno type="doi">10.1016/j.ajic.2018.01.004</idno>
<idno type="wicri:Area/Main/Corpus">000052</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000052</idno>
<idno type="wicri:Area/Main/Curation">000052</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000052</idno>
<idno type="wicri:Area/Main/Exploration">000052</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.</title>
<author><name sortKey="Murti, Michelle" sort="Murti, Michelle" uniqKey="Murti M" first="Michelle" last="Murti">Michelle Murti</name>
<affiliation wicri:level="1"><nlm:affiliation>Fraser Health Authority, Surrey, Canada. Electronic address: Michelle.murti@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fung, Christina K" sort="Fung, Christina K" uniqKey="Fung C" first="Christina K" last="Fung">Christina K. Fung</name>
<affiliation wicri:level="1"><nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chan, Kathy" sort="Chan, Kathy" uniqKey="Chan K" first="Kathy" last="Chan">Kathy Chan</name>
<affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bigham, Mark" sort="Bigham, Mark" uniqKey="Bigham M" first="Mark" last="Bigham">Mark Bigham</name>
<affiliation wicri:level="1"><nlm:affiliation>Fraser Health Authority, Surrey, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Fraser Health Authority, Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">American journal of infection control</title>
<idno type="eISSN">1527-3296</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (administration & dosage)</term>
<term>British Columbia (epidemiology)</term>
<term>Chemoprevention (methods)</term>
<term>Cross Infection (epidemiology)</term>
<term>Cross Infection (pathology)</term>
<term>Cross Infection (prevention & control)</term>
<term>Disease Outbreaks</term>
<term>Health Facilities</term>
<term>Humans</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (pathology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Long-Term Care</term>
<term>Retrospective Studies</term>
<term>Time</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (administration et posologie)</term>
<term>Chimioprévention ()</term>
<term>Colombie-Britannique (épidémiologie)</term>
<term>Flambées de maladies</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (anatomopathologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Infection croisée ()</term>
<term>Infection croisée (anatomopathologie)</term>
<term>Infection croisée (épidémiologie)</term>
<term>Soins de longue durée</term>
<term>Temps</term>
<term>Établissements de santé</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>British Columbia</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Infection croisée</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cross Infection</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Chemoprevention</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Cross Infection</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cross Infection</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Colombie-Britannique</term>
<term>Grippe humaine</term>
<term>Infection croisée</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term>
<term>Health Facilities</term>
<term>Humans</term>
<term>Long-Term Care</term>
<term>Retrospective Studies</term>
<term>Time</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Chimioprévention</term>
<term>Flambées de maladies</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Infection croisée</term>
<term>Soins de longue durée</term>
<term>Temps</term>
<term>Établissements de santé</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To assess the duration of antiviral prophylaxis (AP), we conducted a retrospective outbreak review over 3 seasons, looking for acute respiratory illness (ARI) onset after 5 days of AP. Of 114 facility-level outbreaks with 352 unit-level outbreaks, we found only 1 case of laboratory-confirmed influenza after 5 days of AP. New cases of ARI after 5 days of AP should be investigated, and recommendations for AP duration could be shortened to 7-8 days or less.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29502884</PMID>
<DateCompleted><Year>2019</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>09</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-3296</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>46</Volume>
<Issue>9</Issue>
<PubDate><Year>2018</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>American journal of infection control</Title>
<ISOAbbreviation>Am J Infect Control</ISOAbbreviation>
</Journal>
<ArticleTitle>Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017.</ArticleTitle>
<Pagination><MedlinePgn>1077-1079</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0196-6553(18)30005-1</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajic.2018.01.004</ELocationID>
<Abstract><AbstractText>To assess the duration of antiviral prophylaxis (AP), we conducted a retrospective outbreak review over 3 seasons, looking for acute respiratory illness (ARI) onset after 5 days of AP. Of 114 facility-level outbreaks with 352 unit-level outbreaks, we found only 1 case of laboratory-confirmed influenza after 5 days of AP. New cases of ARI after 5 days of AP should be investigated, and recommendations for AP duration could be shortened to 7-8 days or less.</AbstractText>
<CopyrightInformation>Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murti</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Fraser Health Authority, Surrey, Canada. Electronic address: Michelle.murti@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fung</LastName>
<ForeName>Christina K</ForeName>
<Initials>CK</Initials>
<AffiliationInfo><Affiliation>Fraser Health Authority, Surrey, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chan</LastName>
<ForeName>Kathy</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>University of Toronto, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bigham</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Fraser Health Authority, Surrey, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>03</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Infect Control</MedlineTA>
<NlmUniqueID>8004854</NlmUniqueID>
<ISSNLinking>0196-6553</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001955" MajorTopicYN="N" Type="Geographic">British Columbia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018890" MajorTopicYN="N">Chemoprevention</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Antiviral</Keyword>
<Keyword MajorTopicYN="Y">Influenza</Keyword>
<Keyword MajorTopicYN="Y">Long-term care facility</Keyword>
<Keyword MajorTopicYN="Y">Outbreak</Keyword>
<Keyword MajorTopicYN="Y">Prophylaxis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>10</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2018</Year>
<Month>01</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>01</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>3</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>3</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29502884</ArticleId>
<ArticleId IdType="pii">S0196-6553(18)30005-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.ajic.2018.01.004</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Murti, Michelle" sort="Murti, Michelle" uniqKey="Murti M" first="Michelle" last="Murti">Michelle Murti</name>
</noRegion>
<name sortKey="Bigham, Mark" sort="Bigham, Mark" uniqKey="Bigham M" first="Mark" last="Bigham">Mark Bigham</name>
<name sortKey="Chan, Kathy" sort="Chan, Kathy" uniqKey="Chan K" first="Kathy" last="Chan">Kathy Chan</name>
<name sortKey="Fung, Christina K" sort="Fung, Christina K" uniqKey="Fung C" first="Christina K" last="Fung">Christina K. Fung</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000057 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000057 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= GrippeCanadaV3 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:29502884 |texte= Duration of influenza outbreaks in long-term care facilities after antiviral prophylaxis initiation: Fraser Health, British Columbia, 2014-2017. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29502884" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeCanadaV3
This area was generated with Dilib version V0.6.35. |